Telomir Pharmaceuticals, Inc. (TELO) stock
TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.49−0.01 (-1.96%)
Close on Nov 13, 2026Market cap $33.74MP/E –Yield –
Telomir Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Telomir Pharmaceuticals's total assets was $4.64M at Sep 30, 2026. For fiscal 2025 it was $7.34M, up 454.5% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.34M | +454.5% |
| FY2024 | Dec 31, 2024 | $1.32M | -72.3% |
| FY2023 | Dec 31, 2023 | $4.77M | +9696.4% |
| FY2022 | Dec 31, 2022 | $48.73K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $4.64M | -37.3% |
| Q2 FY2026 | Jun 30, 2026 | $5.37M | +546.8% |
| Q1 FY2026 | Mar 31, 2026 | $5.79M | +1078.7% |
| Q4 FY2025 | Dec 31, 2025 | $7.34M | +454.5% |
| Q3 FY2025 | Sep 30, 2025 | $7.40M | +610.4% |
| Q2 FY2025 | Jun 30, 2025 | $829.61K | -60.5% |
| Q1 FY2025 | Mar 31, 2025 | $491.19K | -86.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.32M | -72.3% |
| Q3 FY2024 | Sep 30, 2024 | $1.04M | +2038.3% |
| Q2 FY2024 | Jun 30, 2024 | $2.10M | – |
| Q1 FY2024 | Mar 31, 2024 | $3.50M | – |
| Q4 FY2023 | Dec 31, 2023 | $4.77M | – |
| Q4 FY2022 | Dec 31, 2022 | $48.73K | – |
See a number that looks wrong?